Market Cap 1.27B
Revenue (ttm) 68.56M
Net Income (ttm) -437.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -638.84%
Debt to Equity Ratio 0.00
Volume 3,933,100
Avg Vol 3,934,508
Day's Range N/A - N/A
Shares Out 139.52M
Stochastic %K 9%
Beta 1.65
Analysts Strong Sell
Price Target $20.78

Company Profile

Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibod...

Industry: Biotechnology
Sector: Healthcare
Phone: 415 906 4324
Website: www.vir.bio
Address:
1800 Owens Street, Suite 900, San Francisco, United States
RobbyAxelrod1
RobbyAxelrod1 Mar. 21 at 7:22 PM
$VIR https://www.sciencealert.com/new-experimental-drug-shrinks-tumors-in-prostate-cancer-clinical-trial
0 · Reply
Mhand
Mhand Mar. 18 at 3:32 PM
$VIR Like clockwork. The MM's have 2 more days to drive the price under $9 to f*ck the majority of options traders. WTF do option traders keep playing into that scam!!??
0 · Reply
soksobay
soksobay Mar. 18 at 1:52 PM
$VIR back to 7.80$
1 · Reply
gba
gba Mar. 17 at 12:21 PM
$VIR Ask this chatgpt “Regarding the VIR stock, please explain in English what is so unique about their technological capability in treating prostate cancer, and go into detail.” this more than gold
0 · Reply
JuliusCoolius
JuliusCoolius Mar. 17 at 12:17 AM
$VIR This is one of those companies with so much potential that it could be a life changing opportunity. IF things materialize as expected we could be looking back at this phase and just smile. This is biotech so there is always the need to have a dose of reality. Trials could unexpectedly fail to make endpoints for example. Going by the data we have seen so far (and which partners have seen), that isn’t going to happen. Hold tight folks. I have held this one from Covid times so this is really a long term hold. Happy with the size of my holdings here. Just not going to worry about the wild swings. Eventually it will move forcefully in one direction. I think that will be UP
0 · Reply
Dunnieboy1
Dunnieboy1 Mar. 16 at 9:03 PM
$VIR all the times the sp has dropped even on good news then the sp goes up when the world is in such a perilous state, suppose early stage biotech is not affected by oil prices etc.
0 · Reply
Aksunbay
Aksunbay Mar. 16 at 7:04 PM
0 · Reply
AshvsEvilDead
AshvsEvilDead Mar. 13 at 4:15 PM
$VIR need help from the longs here. Looking to buy in. I see a gap at 7.85. 8.72 at the top of the new trend. What do we have coming up? Like the tech, obviously strong results, still seems a bit early though. Doing some DD.
0 · Reply
Andy_Flower
Andy_Flower Mar. 12 at 2:19 PM
$VIR almost 7k watchers but a dead group…
1 · Reply
PharmDGi
PharmDGi Mar. 11 at 2:19 PM
$VIR maybe $11-$12 today ? Nice setup forming
0 · Reply
Latest News on VIR
These Analysts Boost Their Forecasts On Vir Biotechnology

Feb 24, 2026, 1:05 PM EST - 25 days ago

These Analysts Boost Their Forecasts On Vir Biotechnology


What's Happening With VIR Stock?

Feb 24, 2026, 4:10 AM EST - 25 days ago

What's Happening With VIR Stock?


Vir Biotechnology, Inc. (VIR) Q4 2025 Earnings Call Transcript

Feb 24, 2026, 2:04 AM EST - 25 days ago

Vir Biotechnology, Inc. (VIR) Q4 2025 Earnings Call Transcript


Vir Biotechnology, Inc. (VIR) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 9:41 PM EST - 4 months ago

Vir Biotechnology, Inc. (VIR) Q3 2025 Earnings Call Transcript


Vir Biotechnology, Inc. (VIR) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 11:01 PM EDT - 8 months ago

Vir Biotechnology, Inc. (VIR) Q2 2025 Earnings Call Transcript


Vir Biotechnology: Hep B And Cancer Projects March On

Jul 23, 2025, 12:10 PM EDT - 8 months ago

Vir Biotechnology: Hep B And Cancer Projects March On


Vir Biotechnology, Inc. (VIR) Q1 2025 Earnings Call Transcript

May 7, 2025, 11:21 PM EDT - 11 months ago

Vir Biotechnology, Inc. (VIR) Q1 2025 Earnings Call Transcript


Vir Biotechnology, Inc. (VIR) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 11:22 PM EST - 1 year ago

Vir Biotechnology, Inc. (VIR) Q4 2024 Earnings Call Transcript


RobbyAxelrod1
RobbyAxelrod1 Mar. 21 at 7:22 PM
$VIR https://www.sciencealert.com/new-experimental-drug-shrinks-tumors-in-prostate-cancer-clinical-trial
0 · Reply
Mhand
Mhand Mar. 18 at 3:32 PM
$VIR Like clockwork. The MM's have 2 more days to drive the price under $9 to f*ck the majority of options traders. WTF do option traders keep playing into that scam!!??
0 · Reply
soksobay
soksobay Mar. 18 at 1:52 PM
$VIR back to 7.80$
1 · Reply
gba
gba Mar. 17 at 12:21 PM
$VIR Ask this chatgpt “Regarding the VIR stock, please explain in English what is so unique about their technological capability in treating prostate cancer, and go into detail.” this more than gold
0 · Reply
JuliusCoolius
JuliusCoolius Mar. 17 at 12:17 AM
$VIR This is one of those companies with so much potential that it could be a life changing opportunity. IF things materialize as expected we could be looking back at this phase and just smile. This is biotech so there is always the need to have a dose of reality. Trials could unexpectedly fail to make endpoints for example. Going by the data we have seen so far (and which partners have seen), that isn’t going to happen. Hold tight folks. I have held this one from Covid times so this is really a long term hold. Happy with the size of my holdings here. Just not going to worry about the wild swings. Eventually it will move forcefully in one direction. I think that will be UP
0 · Reply
Dunnieboy1
Dunnieboy1 Mar. 16 at 9:03 PM
$VIR all the times the sp has dropped even on good news then the sp goes up when the world is in such a perilous state, suppose early stage biotech is not affected by oil prices etc.
0 · Reply
Aksunbay
Aksunbay Mar. 16 at 7:04 PM
0 · Reply
AshvsEvilDead
AshvsEvilDead Mar. 13 at 4:15 PM
$VIR need help from the longs here. Looking to buy in. I see a gap at 7.85. 8.72 at the top of the new trend. What do we have coming up? Like the tech, obviously strong results, still seems a bit early though. Doing some DD.
0 · Reply
Andy_Flower
Andy_Flower Mar. 12 at 2:19 PM
$VIR almost 7k watchers but a dead group…
1 · Reply
PharmDGi
PharmDGi Mar. 11 at 2:19 PM
$VIR maybe $11-$12 today ? Nice setup forming
0 · Reply
PCIntern
PCIntern Mar. 11 at 1:41 PM
$VIR broke $10. Let’s see if they “allow us “ to hold that.
3 · Reply
JuliusCoolius
JuliusCoolius Mar. 10 at 8:55 PM
$AVXL $BIAF $MBOT $VIR Good attempt to slam vir while promoting your other stocks. Here’s the deal though, the market cap means nothing without context. A high margin billion dollar blockbuster could make the company worth 10 times the current market cap. Just remember, current price is only a discounting mechanism for future earnings and profits. Further, approval could come sooner than your “years to go”. Makes me wonder if you even understand the multiple indications and pipeline for this company.
2 · Reply
Logic102
Logic102 Mar. 10 at 3:36 PM
$VIR I absolutely love the recent trial results. Truly fantastic and point to great future success. This is a solid long-term investment. My only problem here is that the Market Cap is already 1.6B and the trial process has years to go. I think the CEO is wise to look for partnerships with upfront payment(s), milestone payments and very healthy royalties. I tend to look for companies that are still highly undervalued with small Market Caps like $MBOT, $AVXL and LCTX. I even have a few very tiny promising names with higher risk like $BIAF Despite, this, I am thinking about taking a position in this name.
0 · Reply
VIR_Tical1
VIR_Tical1 Mar. 9 at 8:26 PM
$VIR Vir CEO Marianne De Backer discusses the progress being made with the firm's leading treatments, the runup in its share price thus far in 2026, and why partnerships are key to advancing Vir's impact. Dr. De Backer speaks with Carol Massar and Tim Stenovec on Bloomberg Businessweek Daily. https://www.bloomberg.com/news/videos/2026-02-27/vir-bio-ceo-on-cancer-treatment-progress-possible-deals-video
1 · Reply
Andy_Flower
Andy_Flower Mar. 9 at 7:50 PM
$VIR breaking the channel.. good vibes on biotech along with $HIMS and $NVO
0 · Reply
Dunnieboy1
Dunnieboy1 Mar. 9 at 2:52 PM
$VIR surprised it’s green today considering what’s going on in the world.
0 · Reply
CantNameThatTune
CantNameThatTune Mar. 8 at 4:41 AM
$RXT Not many people here so things said make no difference. Thursday's sudden late spike tripped alerts everywhere. That was followed Friday by NO upticks and a new low all day. A decided dichotomy for sure. Thursday was NOT a Nasdaq bouncing 300 points in the last 90 minutes. It was news driven, you just haven't seen the news yet. It's kinda like $VIR $CDIO $TMDE $BNAI where suddenly it just reverses and goes for new highs. But for this RXT ALL the right reasons. It's not just the PLTR deal. It's much more than that.
0 · Reply
AceofAllTrader
AceofAllTrader Mar. 8 at 12:13 AM
$VIR very likely.
0 · Reply
Dunnieboy1
Dunnieboy1 Mar. 6 at 10:35 PM
$VIR we traded down to $8.65 then recovered to $9.61, that was a excellent recovery but how the mm’s took it down to $8.65 i don’t know. Anyway what a great recovery & we look all set to go over $10 which would be a great achievement the way the world is at the moment.
1 · Reply
Aksunbay
Aksunbay Mar. 6 at 7:23 PM
$VIR It will soon be even bigger than Ibrx. It will be like Verona and even bigger.
0 · Reply
Dunnieboy1
Dunnieboy1 Mar. 6 at 6:04 PM
$VIR in the green now after falling to $8.62, market makers are ’shaking the tree’, getting nervous hands to sell.
0 · Reply
Dunnieboy1
Dunnieboy1 Mar. 6 at 3:02 PM
$VIR sometimes you wished you never got involved in the madness of share trading.
0 · Reply